原创《注射用复合辅酶对慢性肾脏病患者肾脏保护作用分析》：本文是一篇关于复合辅酶论文范文，可作为相关选题参考,和写作参考文献。
DOI：10.16662/j.cnki.1674-0742.2017.23.163
[摘 要] 目的 分析慢性肾脏病患者治疗中实施注射用复合辅酶方案对其肾脏组织的保护功能. 方法 研究从2016年3月—2017年5月间进入该院接受治疗的慢性肾脏病患者中,方便选取113例,对其随机分组：常规组56例实施谷光甘肽方案,治疗组57例则联合实施注射用复合辅酶方案,再观察其肾功能指数、血压指数以及Hb指数等改善情况.结果 治疗后,治疗组UA指数（302.13±82.15）μmol/L,Cr指数（175.96±49.78）μmol/L,P指数（1.35±0.30）mmol/L,BUN指数（10.00±2.43）mmol/L,Hb指数（108.75±18.66）g/L,Glu指数（4.20±0.40）mmol/L,Alb指数（44.11±2.46）g/L,CHO指数（3.61±1.19）mmol/L,SBP指数（131.68±15.22）mmHg,DBP指数（76.56±10.72）mmHg,均优于常规组（P<0.05）.结论对于出现慢性肾脏疾病的患者,实施注射用复合辅酶方案效果显著,可实现对其肾脏组织的有效保护,可推广.
[关键词] 谷光甘肽；慢性肾脏疾病；临床治疗；注射用复合辅酶；肾脏组织功能
[中图分类号] R4 [文献标识码] A [文章编号] 1674-0742（2017）08（b）-0163-03
Protective Effect Analysis of Injection with Compound Coenzyme Renal in Patients with Chronic Kidney Disease
SUN Li
Department of Nephrology, Xuyi People’s Hospital, Huaian, Jiangsu Province, 211700 China
[Abstracts] Objective This paper tries to analyze the implementation of injection in treatment of patients with chronic kidney disease （CKD） compound coenzyme scheme for the protective function of the kidney tissue. Methods 113 cases of patients with chronic kidney disease（CKD） from March 2016 to May 2017 in this hospital for treatment were conveniently selected and randomly grouped, 56 cases of the routine group adopted glutathione treatment, and 57 cases of the treatment group adopted injection with compound coenzyme renal treatment, the oxidative stress index, the index of renal function, blood pressure index and the index of Hb were observed in the two groups. Results After treatment, the UA index in the treatment group was （302.13±82.15）μmol/L, Cr index was （175.96±49.78）μmol/L, P index was （1.35±0.30）mmol/L, BUN index was （10.00±2.43） mmol/L, Hb index was （108.75±18.66）g/L Glu index was （4.20±0.40）mmol/L, Alb index was （44.11±2.46）g/l, CHO index was （3.61±1.19）mmol/L, SBP index was （131.68±15.22）mmHg, DBP index was （76.56±10.72）mmHg, were better than the routine group（P<0.05）. Conclusion For patients with chronic kidney disease, the effective protection of the renal tissue can be promoted by effective protection of the renal tissue.
[Key words] Glutathione； Chronic kidney disease； Clinical treatment； Injection with compound coenzyme； Kidney tissue function
慢性腎脏疾病治疗中,通过实施注射用复合辅酶方案,可使患者氧化应激指标、肾功能指数、血压指数以及Hb指数等有效改善,确保其疾病缓解[1].为评价慢性肾脏病患者治疗中实施注射用复合辅酶方案的有效性,该次方便抽取113例于2016年3月—2017年5月间进入该院接受治疗的慢性肾脏病患者进行分析,期待可以改善其症状,并且对患者肾脏组织有效保护,现报道如下.
1 资料和方法
1.1 一般资料
研究从进入该院接受治疗的慢性肾脏病患者中,方便选取113例,对其随机分组.常规组56例,30例男性,26例女性；30～75岁,中位值（57.2±10.11）岁.治疗组57例,31例男性,26例女性；33～80岁,中位值（58.1±9.99）岁,2组资料差异无统计学意义（P>0.05）.
复合辅酶论文参考资料：
结论：注射用复合辅酶对慢性肾脏病患者肾脏保护作用分析为关于复合辅酶方面的论文题目、论文提纲、复合辅酶价格论文开题报告、文献综述、参考文献的相关大学硕士和本科毕业论文。
